Hims(US:HIMS) ZACKSยท2025-06-10 22:51Company Performance - Hims & Hers Health, Inc. (HIMS) closed at $55.25, reflecting a -2.83% change from the previous day, underperforming the S&P 500's 0.55% gain [1] - Over the past month, HIMS shares have increased by 2.99%, while the Medical sector and S&P 500 gained 3.49% and 6.29%, respectively [1] Upcoming Financial Results - The upcoming EPS for Hims & Hers is projected at $0.17, indicating a significant 183.33% increase compared to the same quarter last year [2] - Quarterly revenue is expected to reach $551.84 million, up 74.83% from the previous year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $0.73 per share, representing a 170.37% increase from the prior year [3] - Revenue for the fiscal year is estimated at $2.34 billion, reflecting a 58.31% increase from the previous year [3] Analyst Estimates and Outlook - Recent adjustments to analyst estimates indicate a favorable outlook on the company's business health and profitability [4] - The Zacks Consensus EPS estimate has increased by 5.66% over the past month, with Hims & Hers currently holding a Zacks Rank of 2 (Buy) [6] Valuation Metrics - Hims & Hers is currently trading at a Forward P/E ratio of 77.39, which is a premium compared to the industry average of 27.09 [7] - The company's PEG ratio stands at 2.12, aligning with the industry average [7] Industry Context - The Medical Info Systems industry, part of the Medical sector, has a Zacks Industry Rank of 70, placing it in the top 29% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]